Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

UK, Germany and Spain have more than half of global monkeypox cases

The WHO also believes that the amount of cases could be underestimated.

THE WORLD HEALTH Organization (WHO) has released data showing that the global total of monkeypox cases has risen to 3413, 1310 more than its last update on 17 June.

The UK had the highest number of confirmed cases at 793, followed by Germany with 521 and Spain with 520.

These three countries represent more than half of the total cases across the globe.

The vast majority of cases have been recorded in Europe (86%), followed by the Americas (11%), Africa (2%) and the Eastern Mediterranean region and Western Pacific region which have less than 1% of the total cases each.

Portugal had the fourth highest amount of confirmed cases at 317, followed by France (277), Canada (210) and the United States with 142.

50 countries or territories now have confirmed monkeypox cases however the WHO has said that the amount of cases may be much higher, due to Western countries struggling to identify a disease which is usually confined to West and Central African countries. 

“The actual number of cases is likely to be underestimated, in part due to the lack of early clinical recognition of an infection previously known in only a handful of countries,” the organization’s statement read.

HSE figures released last week put the total of cases in Ireland at 28, while all cases so far are among the male population and most are between the ages of 25 and 44.

The WHO has strongly encouraged countries to “review the evidence and develop policy recommendations for the use of vaccines as relevant to the national context.”

It also called on countries to share any data from clinical studies on vaccines and stated that an antiviral drug called Tecorivimat was being studied and expected to be safe for protecting against monkeypox.

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Close
3 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel

     
    JournalTv
    News in 60 seconds